« Med Ad News covers blog attack on BrandweekNRX. | Main | It is good that some drugs are expensive. »

August 20, 2007

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d834519bc269e200e54ecd5b018833

Listed below are links to weblogs that reference Oops. This is not what Edelman PR wanted me to write.:

Comments

Frederick Felman

Peter - thanks for the thoughtful comments. And, on behalf of our CEO, Irfan Salim and me, you are not off our mailing lists now. The online pharmaceutical issue is complex and the study was designed to provoke discussion not cut it off. So thanks for your perspective and for expanding the dialog.

Best,

Frederick Felman, CMO MarkMonitor

Marc Monseau

Peter,

Is nothing sacred? : ) It's fascinating how the mechanics of PR and journalism are now visible to all and discussed openly. Just a point -- you mentioned that "many journalists" wrote the stories, but you didn't provide any links to illustrate this point. Do you have some examples?

Marc

Peter Rost

Frederick, thanks for your kind comments, and Marc, this will help you out . . . http://news.google.com/news?hl=en&lr=&ie=UTF-8&scoring=d&tab=wn&q=Brandjacking&btnG=Search

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

 
© 2010 Brandweek. All rights reserved. Terms Of Use and Privacy Policy Additional Terms Of Use and Privacy Policy.